PepGen Inc. (PEPG)

NASDAQ: PEPG · IEX Real-Time Price · USD
11.79
0.53 (4.71%)
May 17, 2022 3:59 PM EDT - Market closed
Market Cap242.45M
Revenue (ttm)n/a
Net Income (ttm)-27.28M
Shares Out20.56M
EPS (ttm)-1.33
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume76,148
Open11.04
Previous Close11.26
Day's Range9.28 - 12.00
52-Week Range9.28 - 12.75
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About PEPG

PepGen is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Our Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the ro...

IndustryBiotechnology
IPO DateMay 6, 2022
CEOJames McArthur, Ph.D.
Employees31
Stock ExchangeNASDAQ
Ticker SymbolPEPG
Full Company Profile

Financial Performance

Financial Statements

News

PepGen Announces Pricing of Initial Public Offering

BOSTON, May 05, 2022 (GLOBE NEWSWIRE) -- PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of se...

1 week ago - GlobeNewsWire